119 related articles for article (PubMed ID: 15107596)
1. Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2.
Kis A; Baxter GF; Yellon DM
Cardiovasc Drugs Ther; 2003; 17(5-6):415-25. PubMed ID: 15107596
[TBL] [Abstract][Full Text] [Related]
2. AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts.
Liu Y; Yang X; Yang XM; Walker S; Förster K; Cohen MV; Krieg T; Downey JM
Basic Res Cardiol; 2010 Jan; 105(1):129-37. PubMed ID: 19730798
[TBL] [Abstract][Full Text] [Related]
3. Amp 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors.
Xu Z; Downey JM; Cohen MV
J Cardiovasc Pharmacol; 2001 Sep; 38(3):474-81. PubMed ID: 11486252
[TBL] [Abstract][Full Text] [Related]
4. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
[TBL] [Abstract][Full Text] [Related]
5. Cooperative cardioprotection through adenosine A1 and A2A receptor agonism in ischemia-reperfused isolated mouse heart.
Urmaliya VB; Pouton CW; Ledent C; Short JL; White PJ
J Cardiovasc Pharmacol; 2010 Oct; 56(4):379-88. PubMed ID: 20930592
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion.
Budde JM; Velez DA; Zhao Z; Clark KL; Morris CD; Muraki S; Guyton RA; Vinten-Johansen J
Cardiovasc Res; 2000 Aug; 47(2):294-305. PubMed ID: 10946066
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion.
Kuno A; Critz SD; Cui L; Solodushko V; Yang XM; Krahn T; Albrecht B; Philipp S; Cohen MV; Downey JM
J Mol Cell Cardiol; 2007 Sep; 43(3):262-71. PubMed ID: 17632123
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.
Button L; Mireylees SE; Germack R; Dickenson JM
Exp Physiol; 2005 Sep; 90(5):747-54. PubMed ID: 15964902
[TBL] [Abstract][Full Text] [Related]
9. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning.
Yoshimura Y; Kristo G; Keith BJ; Jahania SA; Mentzer RM; Lasley RD
Cardiovasc Drugs Ther; 2004 Nov; 18(6):433-40. PubMed ID: 15770430
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning.
Kristo G; Yoshimura Y; Keith BJ; Stevens RM; Jahania SA; Mentzer RM; Lasley RD
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2746-53. PubMed ID: 15271662
[TBL] [Abstract][Full Text] [Related]
12. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
[TBL] [Abstract][Full Text] [Related]
13. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
14. Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway.
Boucher M; Pesant S; Falcao S; de Montigny C; Schampaert E; Cardinal R; Rousseau G
J Cardiovasc Pharmacol; 2004 Mar; 43(3):416-22. PubMed ID: 15076226
[TBL] [Abstract][Full Text] [Related]
15. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt.
Solenkova NV; Solodushko V; Cohen MV; Downey JM
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H441-9. PubMed ID: 16155103
[TBL] [Abstract][Full Text] [Related]
16. Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C.
Kuno A; Solenkova NV; Solodushko V; Dost T; Liu Y; Yang XM; Cohen MV; Downey JM
Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1288-H1295. PubMed ID: 18660452
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids protect the rat isolated heart against ischaemia.
Lépicier P; Bouchard JF; Lagneux C; Lamontagne D
Br J Pharmacol; 2003 Jun; 139(4):805-15. PubMed ID: 12813004
[TBL] [Abstract][Full Text] [Related]
18. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes.
Xiao L; Pimental DR; Amin JK; Singh K; Sawyer DB; Colucci WS
J Mol Cell Cardiol; 2001 Apr; 33(4):779-87. PubMed ID: 11273730
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A₂A and A₂B receptors are both required for adenosine A₁ receptor-mediated cardioprotection.
Zhan E; McIntosh VJ; Lasley RD
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1183-9. PubMed ID: 21743001
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study.
Kopecky SL; Aviles RJ; Bell MR; Lobl JK; Tipping D; Frommell G; Ramsey K; Holland AE; Midei M; Jain A; Kellett M; Gibbons RJ;
Am Heart J; 2003 Jul; 146(1):146-52. PubMed ID: 12851624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
